Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
| Autor: | Tewari, Krishnansu S., Colombo, Nicoletta, Monk, Bradley J., Dubot, Coraline, Cáceres, M. Valeria, Hasegawa, Kosei, Shapira-Frommer, Ronnie, Salman, Pamela, Yañez, Eduardo, Gümüş, Mahmut, Olivera Hurtado de Mendoza, Mivael, Samouëlian, Vanessa, Castonguay, Vincent, Arkhipov, Alexander, Tekin, Cumhur, Li, Kan, Toker, Sarper, Keefe, Stephen M., Lorusso, Domenica |
|---|---|
| Zdroj: | JAMA Oncology; Feb2024, Vol. 10 Issue 2, p185-192, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|